Here are four key points:
1. An increasing incidence of ankylosing spondylitis cases as well as a rising awareness of treatments will spur market growth.
2. Market barriers include treatment costliness and lack of skilled surgeons and physiotherapists.
3. North America captures the greatest market share due to the prevalence of ankylosing spondylitis as well as technological advancements.
4. China and India will experience the most rapid growth because of a rising number of AS patients and increasing favorable government initiatives.
More articles on devices:
Medtronic, SeaSpine, Zimmer Biomet & more: 17 key notes
Analysts update price targets of NuVasive stock — 3 quick points
DePuy Synthes, Acumed, Stryker market leaders in Japan device market: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
